{"id":"https://openalex.org/W2398545285","doi":null,"title":"Comparison of healthcare utilization among patients treated with alcoholism medications.","display_name":"Comparison of healthcare utilization among patients treated with alcoholism medications.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2398545285","mag":"2398545285","pmid":"https://pubmed.ncbi.nlm.nih.gov/21348558","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4160801"},"language":"en","primary_location":{"id":"pmid:21348558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21348558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2398545285"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4160801/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059037972","display_name":"Tami L. Mark","orcid":"https://orcid.org/0000-0002-5528-881X","observed_orcids":["https://orcid.org/0000-0002-5528-881X"]},"institutions":[{"id":"https://openalex.org/I68384125","display_name":"Thomson Reuters (United States)","ror":"https://ror.org/00m7gt169","country_code":"US","type":"company","lineage":["https://openalex.org/I68384125"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tami L Mark","raw_affiliation_strings":["Thomson Reuters Inc, 4301 Connecticut Ave NW, Ste 330, Washington, DC 20008, USA. tami.mark@thomsonreuters.com","Thomson Reuters Inc, 4301 Connecticut Ave NW, Ste 330, Washington, DC 20008, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters Inc, 4301 Connecticut Ave NW, Ste 330, Washington, DC 20008, USA. tami.mark@thomsonreuters.com","institution_ids":["https://openalex.org/I68384125"]},{"raw_affiliation_string":"Thomson Reuters Inc, 4301 Connecticut Ave NW, Ste 330, Washington, DC 20008, USA","institution_ids":["https://openalex.org/I68384125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101935262","display_name":"Leslie B Montejano","orcid":"https://orcid.org/0000-0002-4542-7257","observed_orcids":["https://orcid.org/0000-0002-4542-7257"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leslie B Montejano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075961872","display_name":"Henry R. Kranzler","orcid":"https://orcid.org/0000-0002-1018-0450","observed_orcids":["https://orcid.org/0000-0002-1018-0450"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry R Kranzler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001794876","display_name":"Mady Chalk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mady Chalk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015054723","display_name":"David R. Gastfriend","orcid":"https://orcid.org/0000-0003-4871-3280","observed_orcids":["https://orcid.org/0000-0003-4871-3280"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David R Gastfriend","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.322,"has_fulltext":false,"cited_by_count":32,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77865203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"12","first_page":"879","last_page":"888"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.9610000252723694},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.8539999723434448},{"id":"https://openalex.org/keywords/disulfiram","display_name":"disulfiram","score":0.9679999947547913},{"id":"https://openalex.org/keywords/acamprosate","display_name":"acamprosate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.8669999837875366},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8349999785423279},{"id":"https://openalex.org/keywords/inpatient-detoxification","display_name":"inpatient detoxification","score":0.8489999771118164},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.9150000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8934909105300903},{"id":"https://openalex.org/C2779992327","wikidata":"https://www.wikidata.org/wiki/Q337668","display_name":"Acamprosate","level":5,"score":0.8061817288398743},{"id":"https://openalex.org/C2778523461","wikidata":"https://www.wikidata.org/wiki/Q409665","display_name":"Disulfiram","level":2,"score":0.7970799803733826},{"id":"https://openalex.org/C2779436514","wikidata":"https://www.wikidata.org/wiki/Q4713263","display_name":"Alcohol dependence","level":3,"score":0.6384754180908203},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.6141409277915955},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5788453221321106},{"id":"https://openalex.org/C2780931562","wikidata":"https://www.wikidata.org/wiki/Q7331102","display_name":"Alcohol abuse","level":2,"score":0.5298300385475159},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5273186564445496},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4822610020637512},{"id":"https://openalex.org/C2779442783","wikidata":"https://www.wikidata.org/wiki/Q15326","display_name":"Alcohol use disorder","level":3,"score":0.4543830156326294},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.4327754080295563},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42809587717056274},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.25758978724479675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15355819463729858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.08866459131240845},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077443","descriptor_name":"Acamprosate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006305","descriptor_name":"Health Status Indicators","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007297","descriptor_name":"Inpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057216","descriptor_name":"Propensity Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:21348558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21348558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:4160801","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4160801/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Manag Care","raw_type":"Text"},{"id":"mag:2398545285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21348558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"mag:2804883483","doi":null,"is_oa":false,"landing_page_url":"https://www.rti.org/publication/comparison-healthcare-utilization-among-patients-treated-alcohol-dependence-medications","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4160801","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4160801/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Manag Care","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G8631410389","display_name":"Novel Approaches to Alcoholism Pharmacotherapy and Risk","funder_award_id":"K24AA013736","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"}],"funders":[{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1553583298","https://openalex.org/W1603135599","https://openalex.org/W1973869640","https://openalex.org/W1983857792","https://openalex.org/W2022881140","https://openalex.org/W2039993999","https://openalex.org/W2042353763","https://openalex.org/W2043239339","https://openalex.org/W2054992104","https://openalex.org/W2062285900","https://openalex.org/W2063443884","https://openalex.org/W2066059923","https://openalex.org/W2067227935","https://openalex.org/W2086175717","https://openalex.org/W2087081361","https://openalex.org/W2101372918","https://openalex.org/W2123760900","https://openalex.org/W2136636673","https://openalex.org/W2138742021","https://openalex.org/W2139226057","https://openalex.org/W2169755310","https://openalex.org/W2416444369","https://openalex.org/W3027683458"],"related_works":["https://openalex.org/W2405516362","https://openalex.org/W1918759949","https://openalex.org/W2083060011","https://openalex.org/W4408512189","https://openalex.org/W4409628191","https://openalex.org/W157606295","https://openalex.org/W2143015721","https://openalex.org/W4410332487","https://openalex.org/W2981001303"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"determine":[2],"in":[3,51,252,266,296],"a":[4,52],"large":[5],"claims":[6,45],"database":[7,37,54],"the":[8,192,210,244,253,267],"healthcare":[9,73,281,297],"utilization":[10,74,130,282,298],"and":[11,24,29,65,72,141,178,299],"costs":[12],"associated":[13,198],"with":[14,19,42,90,99,199,264],"treatment":[15],"of":[16,132,194,212],"alcohol":[17,43,84],"dependence":[18,44,85],"medications":[20,154,295],"vs":[21,161,173,184],"no":[22],"medication":[23,82,270,278],"across":[25],"4":[26,190],"US":[27],"Food":[28],"Drug":[30],"Administration":[31],"(FDA)-approved":[32],"medications.":[33],"STUDY":[34],"DESIGN:":[35],"Claims":[36],"analysis.":[38],"METHODS:":[39],"Eligible":[40],"adults":[41],"(n":[46,86,95,107,113,122],"=":[47,87,103,108,114,123,187,218,224],"27,135)":[48],"were":[49,125],"identified":[50],"commercial":[53],"(MarketScan;":[55],"Thomson":[56],"Reuters":[57],"Inc,":[58],"Chicago,":[59],"Illinois).":[60],"Following":[61],"propensity":[62],"score-based":[63],"matching":[64],"inverse":[66],"probability":[67],"weighting":[68],"on":[69],"demographic,":[70],"clinical,":[71],"variables,":[75],"patients":[76,91,251,265,284],"who":[77,92,151,274,285],"had":[78,93,155,238,257,279],"used":[79],"an":[80,258,276,291],"FDA-approved":[81],"for":[83,128],"2977)were":[88],"compared":[89,127,263],"not":[94],"=2977).":[96],"Patients":[97,150,273],"treated":[98],"oral":[100,105,110,213,268,294],"naltrexone":[101,119,195,214,235,254],"hydrochloride(n":[102],"2064),":[104],"disulfiram":[106,220,247],"2076),":[109],"acamprosate":[111,227],"calcium":[112],"5068),":[115],"or":[116,226,248],"extended-release":[117],"injectable":[118],"(naltrexone":[120],"XR)":[121],"295)":[124],"also":[126,237],"6-month":[129],"rates":[131],"alcoholism":[133,153,269,277],"medication,":[134],"inpatient":[135,139,147,157,170,201,241],"detoxification":[136,158,202],"days,":[137,140,175,216,222,229],"alcoholism-related":[138,169,179,240],"outpatient":[142,259],"services,":[143],"as":[144,146],"well":[145],"charges.":[148],"RESULTS:":[149],"received":[152,275],"fewer":[156,200,239],"days":[159,163,171,203,205,242],"(706":[160],"1163":[162],"per":[164,206],"1000":[165,207],"patients,":[166],"P":[167,176,186,217,223,230],"<.001),":[168,177],"(650":[172],"1086":[174],"emergency":[180],"department":[181],"visits":[182],"(127":[183],"171,":[185],".005).":[188],"Among":[189],"medications,":[191],"use":[193,211],"XR":[196,236,255,289],"was":[197],"(224":[204],"patients)":[208],"than":[209,243,283],"(552":[215],".001),":[219],"(403":[221],".049),":[225],"(525":[228],"<.001).":[231],"The":[232],"group":[233,256],"receiving":[234,246],"groups":[245],"acamprosate.":[249],"More":[250],"substance":[260],"abuse":[261],"visit":[262],"groups.":[271],"CONCLUSION:":[272],"lower":[280],"did":[286],"not.":[287],"Naltrexone":[288],"showed":[290],"advantage":[292],"over":[293],"costs.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2398545285","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
